Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer
Completed · Phase 3
Conditions studied: Gestational Trophoblastic Tumor, Neurotoxicity, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Amifostine may be effective in relieving numbness, tingling, and other symptoms of peripheral neuropathy. It is not yet known whether amifostine is effective in treating peripheral neuropathy in patients who have received chemotherapy for cancer. PURPOSE: This randomized phase III trial is studying amifostine to see how well it works compared to observation in relieving numbness, tingling, and other symptoms of peripheral neuropathy in patients who have received platinum-based chemotherapy (such as cisplatin or carboplatin) for cancer.
Key facts
- Study ID
- NCT00058071
- Run by
- Gynecologic Oncology Group
- People needed
- 100
- Starts
- 2003-03-01
- Last updated by the study team
- 2013-07-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Moores UCSD Cancer Center — La Jolla, California, United States
- Jonsson Comprehensive Cancer Center at UCLA — Los Angeles, California, United States
- George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus — New Britain, Connecticut, United States
- St. Vincent's Medical Center — Jacksonville, Florida, United States
- Ella Milbank Foshay Cancer Center at Jupiter Medical Center — Jupiter, Florida, United States
- Lakeland Regional Cancer Center at Lakeland Regional Medical Center — Lakeland, Florida, United States
- University of Miami Sylvester Comprehensive Cancer Center - Miami — Miami, Florida, United States
- Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center — Savannah, Georgia, United States
- Rush-Copley Cancer Care Center — Aurora, Illinois, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University — Chicago, Illinois, United States
- University of Illinois Cancer Center — Chicago, Illinois, United States
- Ingalls Cancer Care Center at Ingalls Memorial Hospital — Harvey, Illinois, United States
- Hinsdale Hematology Oncology Associates — Hinsdale, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West — Joliet, Illinois, United States
- Regional Cancer Center at Memorial Medical Center — Springfield, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital — Urbana, Illinois, United States
- CCOP - Carle Cancer Center — Urbana, Illinois, United States
- Elkhart General Hospital — Elkhart, Indiana, United States
- Howard Community Hospital at Howard Regional Health System — Kokomo, Indiana, United States
- Center for Cancer Therapy at LaPorte Hospital and Health Services — La Porte, Indiana, United States
- Saint Anthony Memorial Health Centers — Michigan City, Indiana, United States
- CCOP - Northern Indiana CR Consortium — South Bend, Indiana, United States
- Memorial Hospital of South Bend — South Bend, Indiana, United States
- Saint Joseph Regional Medical Center — South Bend, Indiana, United States
- Providence Saint Joseph Medical Center - Burbank — Burbank, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.